Dermata Therapeutics(DRMA) - 2024 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 86-3218736 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.0001 per share DRMA The Nasdaq Capital Market Warrants, exercisable for one share of Common Stock DRMAW The Nasdaq Capital Market Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated Filer ☒ Smaller re ...